Sartorius Stedim Biotech Stock Market Value
SDMHF Stock | USD 209.00 0.06 0.03% |
Symbol | Sartorius |
Sartorius Stedim 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sartorius Stedim's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sartorius Stedim.
12/25/2024 |
| 03/25/2025 |
If you would invest 0.00 in Sartorius Stedim on December 25, 2024 and sell it all today you would earn a total of 0.00 from holding Sartorius Stedim Biotech or generate 0.0% return on investment in Sartorius Stedim over 90 days. Sartorius Stedim is related to or competes with Repligen, Cooper Companies,, Teleflex Incorporated, ResMed, Becton Dickinson, Hologic, and STAAR Surgical. Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwid... More
Sartorius Stedim Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sartorius Stedim's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sartorius Stedim Biotech upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 4.3 | |||
Information Ratio | 0.0689 | |||
Maximum Drawdown | 17.23 | |||
Value At Risk | (2.66) | |||
Potential Upside | 4.71 |
Sartorius Stedim Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sartorius Stedim's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sartorius Stedim's standard deviation. In reality, there are many statistical measures that can use Sartorius Stedim historical prices to predict the future Sartorius Stedim's volatility.Risk Adjusted Performance | 0.059 | |||
Jensen Alpha | 0.1479 | |||
Total Risk Alpha | 0.2378 | |||
Sortino Ratio | 0.0402 | |||
Treynor Ratio | 0.4302 |
Sartorius Stedim Biotech Backtested Returns
At this point, Sartorius Stedim is very steady. Sartorius Stedim Biotech owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0588, which indicates the firm had a 0.0588 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Sartorius Stedim Biotech, which you can use to evaluate the volatility of the company. Please validate Sartorius Stedim's Risk Adjusted Performance of 0.059, semi deviation of 1.64, and Coefficient Of Variation of 1715.03 to confirm if the risk estimate we provide is consistent with the expected return of 0.15%. Sartorius Stedim has a performance score of 4 on a scale of 0 to 100. The entity has a beta of 0.32, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Sartorius Stedim's returns are expected to increase less than the market. However, during the bear market, the loss of holding Sartorius Stedim is expected to be smaller as well. Sartorius Stedim Biotech right now has a risk of 2.53%. Please validate Sartorius Stedim expected short fall, and the relationship between the value at risk and rate of daily change , to decide if Sartorius Stedim will be following its existing price patterns.
Auto-correlation | -0.19 |
Insignificant reverse predictability
Sartorius Stedim Biotech has insignificant reverse predictability. Overlapping area represents the amount of predictability between Sartorius Stedim time series from 25th of December 2024 to 8th of February 2025 and 8th of February 2025 to 25th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sartorius Stedim Biotech price movement. The serial correlation of -0.19 indicates that over 19.0% of current Sartorius Stedim price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.19 | |
Spearman Rank Test | -0.47 | |
Residual Average | 0.0 | |
Price Variance | 64.53 |
Sartorius Stedim Biotech lagged returns against current returns
Autocorrelation, which is Sartorius Stedim pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sartorius Stedim's pink sheet expected returns. We can calculate the autocorrelation of Sartorius Stedim returns to help us make a trade decision. For example, suppose you find that Sartorius Stedim has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Sartorius Stedim regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sartorius Stedim pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sartorius Stedim pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sartorius Stedim pink sheet over time.
Current vs Lagged Prices |
Timeline |
Sartorius Stedim Lagged Returns
When evaluating Sartorius Stedim's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sartorius Stedim pink sheet have on its future price. Sartorius Stedim autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sartorius Stedim autocorrelation shows the relationship between Sartorius Stedim pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Sartorius Stedim Biotech.
Regressed Prices |
Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Sartorius Pink Sheet
Sartorius Stedim financial ratios help investors to determine whether Sartorius Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sartorius with respect to the benefits of owning Sartorius Stedim security.